These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37595030)

  • 1. Steerable Microneedles Enabling Deep Delivery of Photosensitizers and CRISPR/Cas9 Systems for Effective Combination Cancer Therapy.
    Wang T; Chen G; Zhang S; Li D; Wei G; Zhao X; Liu Y; Ding D; Zhang X
    Nano Lett; 2023 Sep; 23(17):7990-7999. PubMed ID: 37595030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene editing of Duchenne muscular dystrophy using biomineralization-based spCas9 variant nanoparticles.
    Li S; Du M; Deng J; Deng G; Li J; Song Z; Han H
    Acta Biomater; 2022 Dec; 154():597-607. PubMed ID: 36243370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal coordination micelles for anti-cancer treatment by gene-editing and phototherapy.
    Zhang C; Wang X; Liu G; Ren H; Li J; Jiang Z; Liu J; Lovell JF; Zhang Y
    J Control Release; 2023 May; 357():210-221. PubMed ID: 36972864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ Injection of pH- and Temperature-Sensitive Nanomaterials Increases Chemo-Photothermal Efficacy by Alleviating the Tumor Immunosuppressive Microenvironment.
    Liu J; Guo L; Rao Y; Zheng W; Gao D; Zhang J; Luo L; Kuang X; Sukumar S; Tu Y; Chen C; Sun S
    Int J Nanomedicine; 2022; 17():2661-2678. PubMed ID: 35733417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Targeting H
    Jung E; Lee J; Lee Y; Seon S; Park M; Song C; Lee D
    ACS Appl Bio Mater; 2021 May; 4(5):4450-4461. PubMed ID: 35006857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled CRISPR-Cas9 Ribonucleoprotein Delivery for Sensitized Photothermal Therapy.
    Chen C; Ma Y; Du S; Wu Y; Shen P; Yan T; Li X; Song Y; Zha Z; Han X
    Small; 2021 Aug; 17(33):e2101155. PubMed ID: 34269521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and construction of IR780- and EGCG-based and mitochondrial targeting nanoparticles and their application in tumor chemo-phototherapy.
    Bao J; Zhao Y; Xu J; Guo Y
    J Mater Chem B; 2021 Dec; 9(48):9932-9945. PubMed ID: 34842269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.
    Wang Y; Tang Y; Zhao XM; Huang G; Gong JH; Yang SD; Li H; Wan WJ; Jia CH; Chen G; Zhang XN
    Acta Biomater; 2022 Nov; 153():481-493. PubMed ID: 36162766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-editing by CRISPR-Cas9 in combination with anthracycline therapy via tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression.
    Wang CS; Chang CH; Tzeng TY; Lin AM; Lo YL
    Nanoscale Horiz; 2021 Sep; 6(9):729-743. PubMed ID: 34323910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.
    Zhang BC; Luo BY; Zou JJ; Wu PY; Jiang JL; Le JQ; Zhao RR; Chen L; Shao JW
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):57362-57372. PubMed ID: 33301289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.
    Zhu G; Wang K; Qin H; Zhao X; Chen W; Xu L; Cao W; Guo H
    J Nanobiotechnology; 2020 Sep; 18(1):124. PubMed ID: 32887622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembled albumin nanoparticles for combination therapy in prostate cancer.
    Lian H; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7777-7787. PubMed ID: 29123392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of doxorubicin and CRISPR/Cas9 or RNAi-expressing plasmid by chitosan-based nanoparticle for cancer therapy.
    Li Q; Lv X; Tang C; Yin C
    Carbohydr Polym; 2022 Jul; 287():119315. PubMed ID: 35422284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting.
    Kim SM; Yang Y; Oh SJ; Hong Y; Seo M; Jang M
    J Control Release; 2017 Nov; 266():8-16. PubMed ID: 28916446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple-Modal Imaging-Guided Chemo-Photothermal Synergistic Therapy for Breast Cancer with Magnetically Targeted Phase-Shifted Nanoparticles.
    Wang L; Chen S; Zhu Y; Zhang M; Tang S; Li J; Pei W; Huang B; Niu C
    ACS Appl Mater Interfaces; 2018 Dec; 10(49):42102-42114. PubMed ID: 30431261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microneedle-Assisted Topical Delivery of Photodynamically Active Mesoporous Formulation for Combination Therapy of Deep-Seated Melanoma.
    Tham HP; Xu K; Lim WQ; Chen H; Zheng M; Thng TGS; Venkatraman SS; Xu C; Zhao Y
    ACS Nano; 2018 Dec; 12(12):11936-11948. PubMed ID: 30444343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 and Chlorophyll Coordination Micelles for Cancer Treatment by Genome Editing and Photodynamic Therapy.
    Zhang C; Wang X; Liu G; Ren H; Liu J; Jiang Z; Zhang Y
    Small; 2023 Apr; 19(17):e2206981. PubMed ID: 36693779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy.
    Li H; Wang K; Yang X; Zhou Y; Ping Q; Oupicky D; Sun M
    Acta Biomater; 2017 Apr; 53():399-413. PubMed ID: 28159715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.